ITIH2 and breast cancer: This study focuses on two potential biomarkers—Inter-Alpha-Trypsin Inhibitor Heavy Chain 2 (ITIH2) and Enolase 1 (ENO1)—which have been identified in previous research as relevant to canine mammary tumors.